- Condition: Inflammatory Joint Diseases
Intervention:
Sponsors: Diakonhjemmet Hospital; Diakonhjemmet Hospital; University Hospital of North Norway; St. Olavs Hospital; Lillehammer Hospital for Rheumatic Diseases; Vestre Viken HF Drammen Hospital
Recruiting - verified April 2012 - Condition: Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott; CATO Research Canada; JSS Medical Research Inc.
Recruiting - verified March 2012 - Condition: Juvenile Idiopathic Arthritis (JIA)
Intervention: Drug: Certolizumab Pegol (CZP)
Sponsors: UCB, Inc.; UCB, Inc.
Recruiting - verified May 2012 - Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Drug: CP-690,550; Drug: CP-690, 550
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Arthritis, Psoriatic
Interventions: Biological: Placebo matching BMS-945429; Biological: BMS-945429; Biological: BMS-945429; Biological: BMS-945429
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified January 2012 - Conditions: Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis; Other Arthritic Conditions (e.g., Psoriatic Arthritis)
Intervention: Behavioral: painACTION: Arthritis
Sponsors: Inflexxion, Inc.; Inflexxion, Inc.
Recruiting - verified October 2011 - Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827; Drug: Placebo; Drug: AMG 827
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Juvenile Idiopahtic Arthritis
Intervention: Drug: etanercept
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab (75 mg); Biological: Secukinumab (150 mg); Biological: Placebo Comparator
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Intervention: Drug: Simponi®
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Psoriasis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast; Drug: • Placebo
Sponsors: Celgene Corporation; Celgene Corporation
Recruiting - verified June 2011 - Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo
Sponsors: Centocor, Inc.; Centocor, Inc.; Schering-Plough (Ireland) Company
Recruiting - verified April 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Psoriasis
Intervention:
Sponsors: Abbott; Abbott
Recruiting - verified January 2012 - Conditions: Psoriatic Arthritis; Psoriasis
Intervention:
Sponsors: Innovaderm Research Inc.; Innovaderm Research Inc.; Amgen
Recruiting - verified October 2011 - Condition: Psoriatic Arthritis
Interventions: Drug: Methotrexate; Drug: Anti-TNF
Sponsors: University of Rochester; University of Rochester; National Psoriasis Foundation
Recruiting - verified October 2011 - Condition: Psoriasis
Intervention: Radiation: UVB-311nm radiation
Sponsors: Medical University of Graz; Medical University of Graz
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis
Intervention: Biological: HUMIRA (adalimumab)
Sponsors: Abbott; Abbott; Veeda Clinical Research, Brussels
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsors: Abbott; Abbott
Not yet recruiting - verified January 2012 - Condition: Arthritis, Psoriatic
Interventions: Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: ustekinumab
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Intervention: Drug: anti-TNF therapy (etanercept or adalimumab)
Sponsors: Imperial College London; Imperial College London
Recruiting - verified September 2011 - Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisConditions: Arthritis, Psoriatic; Psoriasis
Intervention: Other: questionnaire
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Endothelial Dysfunction; Inflammatory Disease Activity
Intervention:
Sponsors: Revmatismesykehuset AS; Revmatismesykehuset AS; Abbott
Recruiting - verified May 2009 - Conditions: Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic
Intervention:
Sponsors: Janssen Inc.; Janssen Inc.
Recruiting - verified May 2012 - Condition: Arthritis
Interventions: Biological: Gardasil; Biological: Gardasil; Biological: Gardasil
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Merck
Recruiting - verified October 2011 - Conditions: Psoriasis; Arthritis, Psoriatic
Interventions: Biological: ustekinumab; Biological: Biological therapies other than infliximab and ustekinumab; Drug: conventional systemic agents; Biological: infliximab
Sponsors: Centocor Ortho Biotech Services, L.L.C.; Centocor Ortho Biotech Services, L.L.C.
Recruiting - verified May 2012
 |
Join Clinical Trials for Psoriatic arthritis, and other forms of Arthritis |
